Autobio Diagnostics Co., Ltd. (SHA:603658)

Autobio Diagnostics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	477.01	465.37	1,486	1,138	769.4	327.55
Short-Term Investments	2,610	3,574	2,333	3,141	3,000	3,092
Trading Asset Securities	411.12	3.61	700.57	-	7.34	85.89
Cash & Short-Term Investments	3,499	4,043	4,521	4,278	3,777	3,505
Cash Growth	-3.62%	-10.57%	5.66%	13.27%	7.75%	303.80%
Accounts Receivable	1,232	1,177	1,181	1,074	1,003	958.87
Other Receivables	42.24	110.74	24.25	34.86	31.69	45.27
Receivables	1,275	1,288	1,206	1,109	1,035	1,004
Inventory	1,096	1,153	778.29	752.3	589.34	475.52
Other Current Assets	61.29	59.25	108.54	113.63	156.62	109.75
Total Current Assets	5,931	6,543	6,613	6,254	5,558	5,095
Property, Plant & Equipment	3,996	3,982	3,883	3,293	2,864	2,276
Long-Term Investments	178.73	172.54	123.31	13.76	1.72	83.42
Goodwill	164.65	164.65	164.65	164.65	164.65	164.65
Other Intangible Assets	133.32	136.09	179.03	203.27	227.85	252.2
Long-Term Deferred Tax Assets	356.07	335.66	274.61	238.73	201.76	157.83
Long-Term Deferred Charges	702.46	382.71	179.23	169.97	137.11	104.66
Other Long-Term Assets	183.04	158.7	137.55	135.59	78.07	3.21
Total Assets	11,645	11,875	11,554	10,472	9,233	8,137
Accounts Payable	1,580	1,135	726.15	1,010	355.24	438.73
Accrued Expenses	261.08	349.51	364.54	335.93	238.07	161.57
Short-Term Debt	117.88	240.21	353.28	113.84	121.39	206.63
Current Portion of Long-Term Debt	-	285	342	-	100.08	-
Current Portion of Leases	7.5	8.34	10.93	12.56	9.78	-
Current Income Taxes Payable	77.69	102.38	137.85	86.48	77.62	28.95
Current Unearned Revenue	146.05	166.11	148.14	135.48	125.1	95.86
Other Current Liabilities	341.71	372.71	400.25	472.27	431.28	325.19
Total Current Liabilities	2,532	2,660	2,483	2,167	1,459	1,257
Long-Term Leases	18.31	20.63	24.64	16.26	26.16	-
Long-Term Unearned Revenue	275.03	214.65	118.98	101.77	75.68	58.29
Long-Term Deferred Tax Liabilities	264.31	284.19	258.03	273.03	269.1	236.61
Other Long-Term Liabilities	5.12	4.25	2.92	2.22	-	-
Total Liabilities	3,094	3,183	2,888	2,560	1,829	1,552
Common Stock	571.42	581.01	586.27	586.27	586.27	450.98
Additional Paid-In Capital	3,358	3,819	4,101	4,101	4,101	4,250
Retained Earnings	4,527	4,676	4,091	3,338	2,590	1,771
Treasury Stock	-	-461.03	-243.3	-243.3	-	-
Comprehensive Income & Other	1.13	1.14	1.03	0.61	-0.07	5.25
Total Common Equity	8,458	8,617	8,535	7,783	7,277	6,477
Minority Interest	92.87	75.27	130.87	129.59	126.49	107.95
Shareholders' Equity	8,551	8,692	8,666	7,912	7,403	6,585
Total Liabilities & Equity	11,645	11,875	11,554	10,472	9,233	8,137
Total Debt	143.69	554.19	730.85	142.66	257.4	206.63
Net Cash (Debt)	3,355	3,488	3,790	4,136	3,520	3,299
Net Cash Growth	9.50%	-7.95%	-8.37%	17.50%	6.70%	20626.03%
Net Cash Per Share	5.86	6.05	6.54	7.08	6.00	5.91
Filing Date Shares Outstanding	571.42	576.91	581.01	581.01	586.27	586.27
Total Common Shares Outstanding	571.42	576.91	581.01	581.01	586.27	586.27
Working Capital	3,399	3,883	4,130	4,087	4,099	3,838
Book Value Per Share	14.80	14.94	14.69	13.39	12.41	11.05
Tangible Book Value	8,160	8,316	8,192	7,415	6,884	6,061
Tangible Book Value Per Share	14.28	14.41	14.10	12.76	11.74	10.34
Buildings	2,627	1,895	1,152	829.25	473.02	472.47
Machinery	2,895	2,916	2,740	2,492	2,283	1,892
Construction In Progress	435.94	987.28	1,591	1,272	1,105	641.8

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.